General MedicationsTOPICALGeneric

GARAMYCIN

GENTAMICIN SULFATE

Standard Dose

EQ 0.1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview GARAMYCIN is listed in Drugs@FDA under application 060463 (ANDA).

Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;TOPICAL - EQ 0.1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1966-03-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview GARAMYCIN is listed in Drugs@FDA under application 060463 (ANDA). Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;TOPICAL - EQ 0.1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1966-03-15 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.